Federal Register / Vol. 71, No. 194 / Friday, October 6, 2006 / Notices 59125 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, T Cell/B 

Cell Mechanisms. 

Date: October 17, 2006. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Calbert A. Laing, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4210, 

MSC 7812, Bethesda, MD 20892, 301–435–

1221, laingc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cognition 

and Perception SRA Conflict Review. 

Date: October 27, 2006. 

Time: 8:30 a.m. to 10:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Helix, 1430 Rhode Island 

Ave., NW., Washington, DC 20005. 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7848, Bethesda, MD 20892, 301–435–

2309, pluded@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Non-HIV 

Microbial Vaccine Development. 

Date: October 30, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Jin Huang, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4095G, MSC 7812, 

Bethesda, MD 20892, 301–435–1187, 

jh377p@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Radiation 

Therapy and Biology SBIR/STTR. 

Date: October 30–31, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Bo Hong, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 6194, MSC 7804, 

Bethesda, MD 20892, 301–435–5879, 

hongb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 ONC–

P (03): Cancer Chemoprevention. 

Date: October 30, 2006. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Zhiqiang Zou, MD, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6190, 

MSC 7804, Bethesda, MD 20892, 301–451–

0132, zouzhiq@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NIDDK PAR 

06 113. 

Date: October 31–November 1, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Daniel F. McDonald, PhD, 

Scientific Review Administrator, Chief, Renal 

and Urological Sciences IRG, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1215, mcdonald@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Molecular, 

Cellular and Developmental Neurobiological 

Small Business Applications. 

Date: October 31, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

20036. 

Contact Person: Michael A. Lang, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4140, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1265, langm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts in Biobehavioral Regulation and 

Learning. 

Date: October 31, 2006. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Jane A. DoussardRoosevelt, PhD, Scientific Review 

Administrator, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892, (301) 435–4445, doussarj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892,93.893, National 

Institutes of Health, HHS) 

Dated: September 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8516 Filed 10–5–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Drug Discovery and 

Molecular Pharmacology Study Section, 

October 5, 2006, 8 a.m. to October 6, 

2006, 5 p.m., Wyndham City Center 

Hotel, 1143 New Hampshire Ave., NW., 

Washington, DC 20037 which was 

published in the Federal Register on 

September 15, 2006, 71 FR 54511–

54512. 

The meeting will be held at the Red 

Lion Hotel on Fifth Avenue, 1415 Fifth 

Avenue, Seattle, WA 98101. The 

meeting dates and time remain the 

same. The meeting is closed to the 

public. 

Dated: September 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8517 Filed 10–5–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of an Exclusive 

License: Development and 

Commercialization of Therapeutic 

Products for Autoimmune Diseases 

Including Rheumatoid Arthritis (RA), 

Inflammatory Bowel Disease (IBD) and 

Psoriasis 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), announces that the 

Department of Health and Human 

Services is contemplating the grant of an 

exclusive license to practice the 

inventions embodied in United States 

Patent Application Number 60/181,909 

entitled ‘‘Identification of a Novel 

Domain in the Tumor Necrosis Factor 

Receptor Family that Mediates Preligand Receptor Assembly and 

Function’’ filed February 11, 2000 (HHS 

Ref. No. E–095–2000/0–US–01); U.S. 

Patent Application No. PCT/US01/ 

04125 entitled ‘‘Identification of a Novel 

Domain in the Tumor Necrosis Factor 

Receptor Family that Mediates Preligand Receptor Assembly and 

Function’’ filed February 9, 2001, 2000 

(HHS Ref. No. E–095–2000/0–PCT–02); 


cprice-sewell on PROD1PC66 with NOTICES